Abstract:Apicomplexan parasites such as Babesia, Theileria, Eimeria, Cryptosporidium and Toxoplasma greatly impact animal health globally, and improved, cost-effective measures to control them are urgently required. These parasites have complex multi-stage life cycles including obligate intracellular stages. Major gaps in our understanding of the biology of these relatively poorly characterised parasites and the diseases they cause severely limit options for designing novel control methods. Here we review potentially important shared aspects of the biology of these parasites, such as cell invasion, host cell modification, and asexual and sexual reproduction, and explore the potential of the application of relatively well-established or newly emerging genetic manipulation methods, such as classical transfection or gene editing, respectively, for closing important gaps in our knowledge of the function of specific genes and proteins, and the biology of these parasites. In addition, genetic manipulation methods impact the development of novel methods of control of the diseases caused by these economically important parasites. Transient and stable transfection methods, in conjunction with whole and deep genome sequencing, were initially instrumental in improving our understanding of the molecular biology of apicomplexan parasites and paved the way for the application of the more recently developed gene editing methods. The increasingly efficient and more recently developed gene editing methods, in particular those based on the CRISPR/Cas9 system and previous conceptually similar techniques, are already contributing to additional gene function discovery using reverse genetics and related approaches. However, gene editing methods are only possible due to the increasing availability of in vitro culture, transfection, and genome sequencing and analysis techniques. We envisage that rapid progress in the development of novel gene editing techniques applied to apicomplexan parasites of veterinary interest will ultimately lead to the development of novel and more efficient methods for disease control.

Chemical Genomics for Studying Parasite Gene Function and Interaction.

Chemoinfectomics in Drug Design and Development

Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets

Chemoproteomics: Towards Global Drug Target Profiling

Infectomics in the Discovery and Development of New Antimicrobial Agents

[Applications of Chemical Genetics in Biomedical Research].

A novel chemogenomic screening platform for scalable antimalarial drug target identification

Chemical genetic approaches to dissect microbiota mechanisms in health and disease

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum

Exploiting Chemical Probes for Identifying Drug Target Proteins

The Progress of Parasite Genomics

Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle

Chemical Proteomics to Identify Molecular Targets of Small Compounds

INFECTOMICS IN THE EXPLOITATION OF NEW ANTIINFECTIVE AGENTS

Advances in the application of genetic manipulation methods to apicomplexan parasites

Genome Mining Offers a New Starting Point for Parasitology Research

Recent advances and method development for drug target identification

Combining CRISPRi and metabolomics for functional annotation of compound libraries

Chemical Genetic Validation of GWAS-derived Disease Loci

Infectomics: genomics and proteomics of microbial infections

Chemogenomic profiling: identifying the functional interactions of small molecules in yeast